Company Data
Passage Bio Inc.
Ticker
PASG
Current Price
$5.74 -10.59%
Market Cap
$17.9M
Price Target
Refer to Report
Volume
48.9K
52wk Range
$5.1239 - $26.6
Overview
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.